EDGAR Filing Documents for 0001104659-15-068331

Form 8-K - Current report:

SEC Accession No. 0001104659-15-068331

Filing Date

2015-09-30

Accepted

2015-09-30 16:32:01

Documents

Period of Report

2015-09-24

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-20464_18k.htm	8-K	27834
2	EX-99.1	a15-20464_1ex99d1.htm	EX-99.1	17378
3	GRAPHIC	g204641mmi001.gif	GRAPHIC	2162
	Complete submission text file	0001104659-15-068331.txt		48903

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034

Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000

Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 151134209
SIC: 2834 Pharmaceutical Preparations